The Anti-Human CD123/IL3RA Antibody (SAA2336) is a highly specific and potent antibody that targets the CD123/IL3RA protein, also known as the Interleukin-3 receptor alpha chain. This protein is found on the surface of certain immune cells, including hematopoietic stem cells, dendritic cells, and basophils.
The biological function of CD123/IL3RA is to bind to Interleukin-3 (IL-3), a cytokine that plays a crucial role in the development and function of immune cells. By targeting CD123/IL3RA, this antibody can disrupt the IL-3 signaling pathway and inhibit the growth and survival of cancer cells.
This antibody has been extensively studied and has shown promising results in the treatment of various types of cancer, including acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes. It has also been used in clinical trials for other diseases, such as chronic myeloid leukemia, multiple myeloma, and solid tumors.
In addition to its potential as a therapeutic agent, the Anti-Human CD123/IL3RA Antibody (SAA2336) is also a valuable tool for research purposes. It can be used in various experimental techniques, including flow cytometry, immunohistochemistry, and Western blotting, to detect and quantify the expression of CD123/IL3RA in different cell types and tissues.
This antibody is produced using advanced recombinant DNA technology, ensuring high specificity and purity. It has been validated for use in both in vitro and in vivo experiments, making it a reliable choice for researchers and clinicians alike.
In summary, the Anti-Human CD123/IL3RA Antibody (SAA2336) is a powerful tool for targeting and studying the CD123/IL3RA protein. Its potential as a therapeutic agent and its versatility in research applications make it an essential addition to any biotech laboratory. Order now to advance your research and contribute to the fight against cancer.
There are no reviews yet.